Sustaining HIV, hepatitis and STIs services amid declining health aid

Redefining the HIV response in Africa through local production of medicines and diagnostics

First-ever guidance for Triple Elimination of mother-to-child transmission of HIV, syphilis and hepatitis B

WHO recommends rapid treatment initiation for people living with HIV and mpox

Integrating HIV, viral hepatitis and sexually transmitted infections with primary health care: learning from countries

New WHO guidance on HIV disclosure for children and adolescents

WHO prequalifies the first triple diagnostic test for HIV, hepatitis B and syphilis, a milestone toward global disease elimination goals

WHO recommends injectable lenacapavir for HIV prevention

WHO-backed integrated testing model strengthens response to mpox, HIV, and syphilis

FDA approval of injectable lenacapavir marks progress for HIV prevention

Botswana advances to gold tier on the Path to Elimination of mother-to-child transmission of HIV

HIV, Hepatitis and Sexually Transmitted Infections agenda at the Seventy-eighth World Health Assembly

WHO and Medicines Patent Pool announce sublicensing agreement for rapid diagnostic test technology

WHO supporting countries of the Global Alliance to end AIDS in children and adolescents by 2030

Low-cost, quality-assured HIV tests to sustain access to life-saving services

WHO’s rapid response to sustain HIV, hepatitis and STI services

New study highlights the potential impact of funding cuts on the HIV response

WHO announces the development of updated guidance on HIV service delivery

Protecting key populations from abrupt disruptions to essential HIV services

WHO champions data quality for stronger HIV programmes

Public notice and comment on new members of the Global Validation Advisory Committee (GVAC)